Lm-LLO-Based Immunotherapies and HPV-Associated Disease

Table 1

Modification of Lm-LLO-based immunotherapy for HPV-associated cervical cancer.

Vaccine name	Design	Strain modification	Antigen	Ref.
ADXS11-001 (Lm-LLO-E7)	Plasmid	prfA ^−	E7, HPV-16	[7]
Lm-PEST-E7	Plasmid	prfA ^−	E7, HPV-16	[8]
Lm-ActA-E7	Plasmid	prfA ^−	E7, HPV-16	[8]
Lm-dd-TV	Plasmid	dal ^−dat ^−	E7, HPV-16	[9]